Erratum: A New Tool for CRISPR-Cas13a-BasedCancer Gene Therapy

Mol Ther Oncolytics. 2021 Nov 8:23:367-377. doi: 10.1016/j.omto.2021.10.007. eCollection 2021 Dec 17.

Abstract

[This corrects the article DOI: 10.1016/j.omto.2020.09.004.].

Publication types

  • Published Erratum